COVENTRY: Margaret Keenan, 90, is applauded by staff at the University Hospital on Tuesday after becoming the first person in Britain to receive the Covid-19 vaccine, produced by Pfizer and BioNTech, at the start of the largest immunisation programme in British history. Britain is the first country in the world to start vaccinating people against Covid-19 with the Pfizer/BioNTech jab.—Reuters
COVENTRY: Margaret Keenan, 90, is applauded by staff at the University Hospital on Tuesday after becoming the first person in Britain to receive the Covid-19 vaccine, produced by Pfizer and BioNTech, at the start of the largest immunisation programme in British history. Britain is the first country in the world to start vaccinating people against Covid-19 with the Pfizer/BioNTech jab.—Reuters

LONDON: Britain became the first Western country to start a mass coronavirus vaccine campaign on Tuesday with a 90-year-old receiving the initial jab, as the number of cases in Europe hit 20 million.

Kicking off Britain’s “V-Day”, Margaret Keenan said she felt “privileged” to be given the injection, the first of millions expected to be administered in the hard-hit country over the coming months.

The Pfizer-BioNTech jab is one of several vaccines bringing hope for an end to the pandemic that has killed more than 1.5m people worldwide and ravaged economies.

“My advice to anyone offered the vaccine is to take it,” said Keenan, wearing a mask and a penguin T-shirt. “If I can have it at 90 then you can have it too.”

The UK’s second jab reportedly went to a man named William Shakespeare. The over-80s, care home workers, and at-risk health and social care staff will be at the front of the line.

Almost 40 per cent of the new cases detected over the last seven days worldwide have been in Europe, the region topping 20m cases on Tuesday. But the rate of infection appears to be stabilising.

Russia, one of Europe’s hardest-hit countries in terms of cases, began vaccinating high-risk workers with its own jab on Saturday, and Beijing has also begun an emergency inoculation campaign with a medicine made in China.

The United States is expected to grant emergency authorisation for the Pfizer-BioNTech vaccine later this week, announcing on Tuesday that no concerns had been found in trial data.

Despite the vaccination news, curbs continue to be re-imposed — roughly 30m people in the US state of California are now under stay-at-home orders.

And the World Health Organisation has warned that successful vaccines on their own will not immediately end the crisis.

America’s floundering efforts to quell the pandemic have been widely criticised — the nation is the world’s worst-hit with more than 283,000 deaths.

California ordered most offices to close and banned gatherings among different households. Bars and services such as hair salons were shut and restaurants were allowed to serve takeaway only.

Non-essential travel was also temporarily restricted statewide as California experienced record new Covid-19 cases.

“The overwhelming majority of Californians are now in this new stay-at-home order protocol,” said state Governor Gavin Newsom, who earlier warned that the state hospital system risked being overwhelmed.

The US Food and Drug Administration on Tuesday said data from trials of Pfizer-BioNTech drug revealed “no specific safety concerns”.

The data “suggest a favourable safety profile, with no specific safety concerns identified that would preclude issuance of an EUA (emergency use authorisation)”, it said.

The FDA is also expected to give the green light to the Moderna vaccine. Canadian Prime Minister Justin Trudeau said Pfizer and BioNTech will deliver their first doses to his nation within weeks.

In India, two pharmaceutical firms — including Serum Institute, the world’s biggest manufacturer of vaccines — on Monday sought fast-track approval for coronavirus shots.

India is the second-worst hit nation having already recorded more than 140,000 deaths.

And in Brazil’s Sao Paulo state — Latin America’s coronavirus epicentre — authorities will launch a campaign from January providing the Chinese-developed vaccine CoronaVac to healthcare workers, older people and other vulnerable groups first.

Published in Dawn, December 9th, 2020

Opinion

Editorial

Judiciary’s SOS
Updated 28 Mar, 2024

Judiciary’s SOS

The ball is now in CJP Isa’s court, and he will feel pressure to take action.
Data protection
28 Mar, 2024

Data protection

WHAT do we want? Data protection laws. When do we want them? Immediately. Without delay, if we are to prevent ...
Selling humans
28 Mar, 2024

Selling humans

HUMAN traders feed off economic distress; they peddle promises of a better life to the impoverished who, mired in...
New terror wave
Updated 27 Mar, 2024

New terror wave

The time has come for decisive government action against militancy.
Development costs
27 Mar, 2024

Development costs

A HEFTY escalation of 30pc in the cost of ongoing federal development schemes is one of the many decisions where the...
Aitchison controversy
Updated 27 Mar, 2024

Aitchison controversy

It is hoped that higher authorities realise that politics and nepotism have no place in schools.